South Africa's Tutu back in hospital after surgery
- AT&T (T) Agrees to Acquire Time Warner (TWX) for More than $80 Billion - WSJ
- Top 10 News for 10/17 - 10/21: Merger Rumors Abound; CEOs Depart; Tesla Kicks Autopilot Up A Notch
- Wall Street ends little changed; Microsoft hits record
- AT&T (T) in Advanced Talks to Acquire Time Warner (TWX) - DJ
- Rockwell Automation (ROK) Said to Attract Takeover Interest from Schneider Electric - Source
The former Anglican archbishop of Cape Town Desmond Tutu waits to receive the 2013 Templeton Prize at the Guildhall in central London in this file photo dated May 21, 2013. REUTERS/Paul Hackett/File Photo
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
CAPE TOWN (Reuters) - South African cleric and anti-apartheid icon Desmond Tutu was readmitted to hospital on Saturday to treat an infection following a surgery last week, his family said.
Tutu, the former Anglican archbishop of Cape Town, was discharged from hospital on Wednesday after a successful surgery to treat recurring infections that have afflicted him in the past.
"The archbishop underwent the surgical procedure 10 days ago to address the cause of recurring infections resulting from past treatment received for prostate cancer," the family said in a brief statement.
"The archbishop was readmitted on Saturday as a precaution after his surgical wound had shown signs of infection."
The 84-year-old Nobel Peace Prize winner spoke against white-minority rule from his pulpit, earning him global acclaim.
(Writing by Olivia Kumwenda-Mtambo Editing by Jeremy Gaunt.)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- British anti-terrorist police find second 'suspicious item' after London arrest
- Exclusive: Goldman Sachs' Latam investment bank chief to leave - source
- Colombia airline restarts Venezuela flights after warplane incident
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!